Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 226: Line 226:
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Complete
|Complete
Line 237: Line 237:
|
|
|-
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH / MS
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS
|PENDING
|PENDING
|
|
Line 262: Line 262:
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH / MS
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS
|Complete
|Complete
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|JH / MS
|JH / MS
|Complete
|Complete
Line 308: Line 308:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy via Greg Conboy (Monash Health)||JH / MS
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
|Complete
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH / MS
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
|Complete
|Complete
|
|
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH / MS
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)||JH / MS
|Complete
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident (Iris Martin)||JH / MS
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS
|Complete
|Complete
|
|
Line 333: Line 333:
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH / MS
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS
|Complete
|Complete
|
|
|Check reference format
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS
|Complete
|Complete
|
|
Line 383: Line 383:
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH / MS
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang||JH / MS
|Complete
|Complete
|
|
Line 408: Line 408:
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH / MS
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS
|Complete
|Complete
|
|
Line 418: Line 418:
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH / MS
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS
|Complete
|Complete
|
|
Line 433: Line 433:
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH / MS
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS
|Complete
|Complete
|
|
Line 455: Line 455:
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Disease
|Kay Weng Choy via Greg Conboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|JH / MS
|JH / MS
|Complete
|Complete
Line 463: Line 463:
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Disease
|Daynna Wolff+Path Resident
|Daynna Wolff+Jessica Snider (Path Resident)
|JH / MS
|JH / MS
|PENDING
|PENDING
Line 471: Line 471:
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Disease
|Daynna Wolff+Path Resident
|Daynna Wolff+ Paige Woodham (Path Resident)
|JH / MS
|JH / MS
|PENDING
|PENDING